NZ515353A - Cyclothiocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclothiocarbamate derivatives as progesterone receptor modulators

Info

Publication number
NZ515353A
NZ515353A NZ515353A NZ51535300A NZ515353A NZ 515353 A NZ515353 A NZ 515353A NZ 515353 A NZ515353 A NZ 515353A NZ 51535300 A NZ51535300 A NZ 51535300A NZ 515353 A NZ515353 A NZ 515353A
Authority
NZ
New Zealand
Prior art keywords
receptor modulators
progesterone receptor
cyclothiocarbamate
derivatives
cyclothiocarbamate derivatives
Prior art date
Application number
NZ515353A
Other languages
English (en)
Inventor
Puwen Zhang
Andrew Fensome
Eugene A Terefenko
Lin Hi
Todd K Jones
Christopher M Tegley
Jaye Wrobel
James P Edwards
Mark A Collins
Original Assignee
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc
Publication of NZ515353A publication Critical patent/NZ515353A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ515353A 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators NZ515353A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011749 WO2000066570A1 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
NZ515353A true NZ515353A (en) 2004-03-26

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ515353A NZ515353A (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Country Status (24)

Country Link
EP (1) EP1175411B1 (https=)
JP (2) JP4958338B2 (https=)
KR (1) KR100732692B1 (https=)
CN (1) CN1131856C (https=)
AT (1) ATE386729T1 (https=)
AU (1) AU766801B2 (https=)
BG (1) BG65277B1 (https=)
BR (1) BR0010214A (https=)
CA (1) CA2371712C (https=)
CZ (1) CZ20013952A3 (https=)
DE (1) DE60038108T2 (https=)
DK (1) DK1175411T3 (https=)
EA (1) EA004511B1 (https=)
ES (1) ES2301482T3 (https=)
GE (1) GEP20043181B (https=)
HU (1) HUP0203332A3 (https=)
IL (1) IL146298A0 (https=)
MX (1) MXPA01011287A (https=)
NO (1) NO321370B1 (https=)
NZ (1) NZ515353A (https=)
PL (1) PL351083A1 (https=)
SG (1) SG120970A1 (https=)
SK (1) SK15922001A3 (https=)
TR (1) TR200103285T2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386729T1 (de) * 1999-05-04 2008-03-15 Wyeth Corp Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
ATE409699T1 (de) * 2004-04-08 2008-10-15 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
ATE413398T1 (de) * 2004-04-08 2008-11-15 Wyeth Corp Thioamidderivate als progesteronrezeptormodulatoren
EP1756072A2 (en) * 2004-04-27 2007-02-28 Wyeth Purification of progesterone receptor modulators
CA2562160C (en) * 2004-04-27 2013-05-28 Wyeth Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
WO2006014476A1 (en) * 2004-07-07 2006-02-09 Wyeth Cyclic progestin regimens and kits
SI1778710T1 (sl) 2004-08-13 2012-05-31 Wyeth Llc Derivati tanaprogeta metaboliti in njihove uporabe
EP1877059B8 (en) 2005-04-28 2010-05-19 Wyeth a Corporation of the State of Delaware Micronized tanaproget and compostions containing same
JP2008539254A (ja) * 2005-04-28 2008-11-13 ワイス タナプロゲットの精製形態
SI1896034T1 (sl) 2005-04-28 2010-07-30 Wyeth Llc Mikronizirani sestavki tanaprogeta in postopki priprave le-tega
WO2007030153A2 (en) * 2005-04-28 2007-03-15 Wyeth Compositions containing micronized tanaproget
BRPI0610433A2 (pt) * 2005-04-28 2010-11-23 Wyeth Corp forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
CN103989687A (zh) * 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5696130A (en) * 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Tricyclic steroid receptor modulator compounds and methods
EP1043325B1 (en) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
ES2203790T3 (es) * 1996-10-02 2004-04-16 Bristol-Myers Squibb Pharma Company 1,4-dihidro-2h-3,1-benzoxacin-2-onas 4,4-disustituidas utiles como inhibidores de la transcriptasa reversa del hiv e intermedios y procedimientos para su preparacion.
ATE386729T1 (de) * 1999-05-04 2008-03-15 Wyeth Corp Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren
EP1877059B8 (en) * 2005-04-28 2010-05-19 Wyeth a Corporation of the State of Delaware Micronized tanaproget and compostions containing same
CN103989687A (zh) * 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物

Also Published As

Publication number Publication date
EA004511B1 (ru) 2004-04-29
JP4958338B2 (ja) 2012-06-20
SG120970A1 (en) 2006-04-26
BG106080A (en) 2002-05-31
CA2371712A1 (en) 2000-11-09
JP2012087129A (ja) 2012-05-10
PL351083A1 (en) 2003-03-10
BR0010214A (pt) 2002-02-13
ATE386729T1 (de) 2008-03-15
CN1131856C (zh) 2003-12-24
KR100732692B1 (ko) 2007-06-27
IL146298A0 (en) 2002-07-25
CZ20013952A3 (cs) 2002-05-15
BG65277B1 (bg) 2007-11-30
ES2301482T3 (es) 2008-07-01
JP2002543192A (ja) 2002-12-17
AU4811900A (en) 2000-11-17
EP1175411B1 (en) 2008-02-20
DK1175411T3 (da) 2008-06-09
JP5523430B2 (ja) 2014-06-18
EP1175411A1 (en) 2002-01-30
NO20015381L (no) 2002-01-03
KR20020000170A (ko) 2002-01-04
TR200103285T2 (tr) 2002-02-21
CA2371712C (en) 2009-12-22
EA200101181A1 (ru) 2002-04-25
NO321370B1 (no) 2006-05-02
NO20015381D0 (no) 2001-11-02
DE60038108T2 (de) 2009-02-12
GEP20043181B (en) 2004-02-25
AU766801B2 (en) 2003-10-23
HUP0203332A2 (hu) 2003-01-28
DE60038108D1 (de) 2008-04-03
CN1349516A (zh) 2002-05-15
SK15922001A3 (sk) 2002-09-10
HUP0203332A3 (en) 2004-12-28
MXPA01011287A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
NZ515353A (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
WO2004000801A3 (en) Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
WO2004000225A3 (en) Use of thio-oxindole derivatives in treatment of hormone-related conditions
WO2000066165A8 (en) Contraceptive compositions containing quinazolinone and benzoxazine derivatives
WO2007016385A3 (en) Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators
MXPA05005897A (es) Derivados tetraciclicos novedosos, que contienen heteroatomos, como moduladores selectivos del receptor de estrogeno.
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
CY1106610T1 (el) Μεθοδος για την προληψη ή την θεραπευτικη αντιμετωπιση καλοηθων γυναικολογικων διαταραχων
CY1110017T1 (el) Μικρονισμενη ταναπρογετη και συνθεσεις που περιεχουν αυτην
FI963036A0 (fi) Munasarjan estrogeenista riippuvaisten tilojen hoito
TW200716621A (en) Polymorph form II of tanaproget
TW200716129A (en) Micronized tanaproget, compositions, and methods of preparing the same
MX2009001698A (es) Derivados de oxazolidona como moduladores pr.
WO2000066225A8 (en) Contraceptive compositions containing cyclic carbamates and amide derivatives
DE602005019905D1 (de) -modulatoren
WO2002056903A3 (en) Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
ATE275973T1 (de) Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten
ATE277913T1 (de) Bisarylderivate mit fsh rezeptor modulierender aktivität
PL1874278T3 (pl) Kompozycje zawierające mikronizowany tanaproget
MX2009009515A (es) Cianopirrol sulfonamidas utiles para la modulacion del receptor de progesterona.
PL1809602T3 (pl) Pochodne indolowe przydatne jako modulatory receptora progesteronu
AR023854A1 (es) Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos
AR029632A1 (es) Derivados indol-2-ona, composicion farmaceutica que los comprende y el uso de dichos derivados para la preparacion de medicamentos
RU97117160A (ru) Применение антиэстрогенов для контроля мужской фертильности
UY26967A1 (es) Derivados 8beta-sustituidos de 11beta-pentil y 11beta-hexil-estra-1,3,5(10)-trieno.-

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: WYETH, US

Free format text: OLD OWNER(S): LIGAND PHARMACEUTICALS, INC.; WYETH

RENW Renewal (renewal fees accepted)